EU research to give priority to rheumatic and musculoskeletal conditions

The European Parliament Leading Committee on the Horizon 2020 Programme (the EU Research Framework Programme which will determine EU funding for research from 2014 to 2020) voted on the Commission proposal. We are very pleased to inform you that the compromised amendments on Health, addressing the burden of certain chronic conditions, mentions explicitly rheumatic and musculoskeletal conditions. This is major development for the musculoskeletal community as MSDs will now be prioritised in the next EU Research Programme, running for 7 years.

 A final vote in plenary will take place once the EU decide on the Multiannual Financial Framework , which will in particular determine the final envelope for Horizon 2020. The Commission has proposed an envelope for 80€ billion (this covers all areas of research including health research), the European Parliament is advocating for a 100€billion. Negotiations are on-going between the EU institutions. It is hoped that the final budget of Horizon 2020 will be decided before spring 2013.

Please click on the image above to find out more..